title: Therapeutic apheresis in children: experience in a pediatric dialysis center.
abstract: The use of apheretic procedures in pediatric patients has always been restricted by technical difficulties and the low incidence of diseases requiring this kind of treatment. The aim of the present study was to describe the solutions adopted to solve technical difficulties related to priming, vascular access and monitoring and then to evaluate clinical results. Between 1982 and 2000, 51 consecutive children (28 male, 23 female) with a mean age of 4.9 +/- 4.8 years (3 months-14.8 years) and a mean weight of 19.7 +/- 12.8 kg (5-52 kg), with renal and/or extra-renal diseases requiring apheretic procedures were selected for the study. The overall number of procedures performed were: 226 plasma-exchange (PE), 6 LDL-apheresis (LDL-A) and 8 protein A immunoadsorption (IAPA) sessions. Our therapeutic protocol involves hematic flux of 20-100 ml/min and ultrafiltration of 5-20 ml/min. In each 70-95 minute session we exchanged plasmatic volume with fresh frozen plasma or with a solution of 6% albumin in lactated Ringer's, using heparin (10-20 UI/kg/h). We used Paired Filtration Dialysis Monitor in PE and LDL-A; Citem 10 in IAPA. As plasma separator, we used a filter made of polypropylene, 0.2 m2 surface, 30 ml priming (Hemaplex BT 900). Hemolytic uremic syndrome was the most commonly treated disease (18/51 cases) with good results in 10/18 cases. We recorded, good results in vasculitis as well, in one girl with focal glomerulosclerosis in transplanted kidney and rapid improvement in all children with Guillaine-Barré Syndrome. PE treatment was effective in metabolic disorders such as tirosynemia and familiar hypercholesterolemia. Only 4/12 patients with acute liver failure due to viral hepatitis recovered. We had poor results in the remaining eight cases. Complications were rare and no viral infection was found in any patient. Our data show that it is possible to use these procedures in pediatric patients even though clinical indications and real effectiveness still need to be cleared up.
authors.affiliation: Pediatric Nephrology and Dialysis, Children Hospital Giovanni XXIII, Bari, Italy. todepalo@tin.it
authors.forename: T
authors.initials: T
authors.lastname: De Palo
authors.forename: M
authors.initials: M
authors.lastname: Giordano
authors.forename: R
authors.initials: R
authors.lastname: Bellantuono
authors.forename: V
authors.initials: V
authors.lastname: Colella
authors.forename: D
authors.initials: D
authors.lastname: Troise
authors.forename: F
authors.initials: F
authors.lastname: Palumbo
authors.forename: D A
authors.initials: DA
authors.lastname: Caringella
mesh_terms: D000293:Adolescent; D001781:Blood Component Removal / Q000379:methods*; D002648:Child; D002675:Child, Preschool; D005260:Female; D006776:Hospitals, Pediatric; D006801:Humans; D007223:Infant; D007674:Kidney Diseases / Q000628:therapy*; D017114:Liver Failure, Acute / Q000628:therapy*; D008297:Male; D009422:Nervous System Diseases / Q000628:therapy*; D010951:Plasma Exchange / Q000379:methods*; D016896:Treatment Outcome